July, 2016: Lawsuit against AstraZeneca re Nexium

A Tenlawsuit against re Nexiumnessee man has filed a federal lawsuit against AstraZeneca re Nexium. He blames his diagnosis of interstitial nephritis on the popular heartburn drug, Nexium.  Charles Bowers, plaintiff, says he began regular use of the drug in July 2003 and continued until May 2008 until the time he was diagnosed with the chronic disease. Bowers is currently undergoing dialysis treatment three times a week while awaiting a kidney transplant.

AstraZeneca, the manufacturer of the drug, has been accused of downplaying the risk of nephritis as well as other long-term kidney-related side effects.  Nexium was first linked to nephritis in 2004, yet the label was not changed indicating the potential danger until 2014.

Read the filing in the U.S. District Court for the Western District of Tennessee – Case No. 2:16-cv-02549 here.



Sanders Phillips Grossman has been holding pharmaceutical companies responsible for injuring individuals by their defective drugs and devices for over 30 years. Defective drugs are pharmaceuticals with side effects that potentially harm, injure, or kill the patient to the point that they outweigh the drug’s intended benefits. Defective devices, such as faulty prosthetics, implants, pacemakers, or surgical instruments can harm patients when the product is defective in the manufacturing process, design, or marketing strategy.

Pharmaceutical companies are some of the largest, wealthiest, and most influential corporate entities in the world. Sanders Phillips Grossman and its predecessors have recovered over one billion dollars for injured consumers. Our firm’s history in dealing with drug and medical device injury claims has allowed us to take leadership roles in many of the national defective drug and device litigations.

Nationally recognized as a leading plaintiff’s law firm, we handle cases in all 50 states and Puerto Rico.

Read more about our attorneys here.